How mRNA-LNP medicines span disease areas and future technologies (IMAGE)
Caption
mRNA-LNPs provide a common delivery framework across infectious disease, oncology, autoimmunity, rare genetic disease and tissue repair. The lower panel highlights active extrahepatic targeting, AI-assisted sequence and UTR design, and longer-expression RNA formats.
Credit
©Science Bulletin
Usage Restrictions
use with credit.
License
Original content